UroGen Pharma Ltd (URGN)

전일 마감가:

$12.97

열려 있는:

$13.13

하루 거래량:

618.94K

시가총액:

$497.87M

수익:

$82.71M

순이익/손실:

$-102.24M

주가수익비율:

-2.9444

EPS:

-4.68

순현금흐름:

$-76.57M

1주 성능:

+3.84%

1개월 성능:

-8.74%

6개월 성능:

+19.00%

1년 성능:

+16.68%

1일 변동 폭

$13.13

$14.05

52주 변동 폭

$8.69

$24.13

UroGen Pharma Ltd Stock (URGN) Company Profile

명칭

UroGen Pharma Ltd

부문

Healthcare (1210)

산업

Biotechnology (699)

전화

972 9 770 7601

주소

9 HaTaasiya Street, Ra'anana

직원

42

트위터

@UroGenPharma

다음 수익 날짜

2024-05-20

최신 SEC 제출 서류

URGN's Discussions on Twitter

UroGen Pharma Ltd Stock (URGN) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-02-08	다운그레이드	Jefferies	Buy → Hold
2022-04-27	개시	Berenberg	Buy
2020-04-16	재확인	H.C. Wainwright	Buy
2020-04-13	재확인	H.C. Wainwright	Buy
2020-01-09	개시	National Securities	Neutral
2019-05-30	개시	JP Morgan	Neutral
2019-05-29	개시	Goldman	Neutral
2019-01-29	개시	H.C. Wainwright	Buy
2018-11-08	재개	Jefferies	Buy
2018-04-04	업그레이드	Raymond James	Mkt Perform → Outperform
2018-01-02	개시	Ladenburg Thalmann	Buy
2017-11-15	재확인	Oppenheimer	Outperform
2017-11-15	다운그레이드	Raymond James	Outperform → Mkt Perform

모두보기

UroGen Pharma Ltd 주식(URGN)의 최신 뉴스

Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?

Zacks Investment Research

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Urogen Pharma (URGN) Reports Q4 Loss, Tops Revenue Estimates

Zacks Investment Research

Nurix Therapeutics, Inc. (NRIX) Surges 5.1%: Is This an Indication of Further Gains?

Zacks Investment Research

Two Months After Hamas Attacks, Gaza Conflict Intensifies As Ceasefire Efforts Falter

Benzinga

UroGen Pharma Ltd (URGN) 재무 분석

UroGen Pharma Ltd (URGN) 매출 2024

UroGen Pharma Ltd (URGN) 순이익 2024

UroGen Pharma Ltd (URGN) 현금흐름 2024

UroGen Pharma Ltd (URGN) 주당 순이익 2024